Eris Lifesciences Limited has informed the Exchange about Transcript
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences has submitted a regulatory filing informing exchanges that the transcript of its analyst and investor conference call (held after Q4FY26 results announcement) is now available on the company website. This is a standard disclosure practice following quarterly earnings calls. The actual transcript content is not included in this filing - investors must visit the company website to access the full discussion.
This filing indicates transparency in sharing management commentary with public investors. The actual impact on the stock will depend on the content discussed in the call, which is not provided in this notification. Shareholders should review the full transcript on the company website for insights into management's outlook.